Alexander Knuth - Selected Publications#

T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures.
A Knuth, B Danowski, HF Oettgen, LJ Old. Proceedings of the National Academy of Sciences, 1984; 81 (11), 3511-3515

Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.
A Knuth, T Wölfel, E Klehmann, T Boon, KH Meyer zum Büschenfelde. Proceedings of the National Academy of Sciences, 1989; 86 (8), 2804-2808

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.
Pierre van der Bruggen, Catia Traversari, Patrick Chomez, Christophe Lurquin, Etienne De Plaen, Benoit Van den Eynde, Alex Knuth, Thierry Boon. Science, 1991, 254 (5038), 1643-1647

Simultaneous humoral and cellular immune response against cancer–testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2–binding peptide epitopes.
Elke Jäger, Yao-Tseng Chen, Jan W Drijfhout, Julia Karbach, Mark Ringhoffer, Dirk Jäger, Michael Arand, Hisashi Wada, Yuji Noguchi, Elisabeth Stockert, Lloyd J Old, Alexander Knuth. The Journal of Experimental Medicine, 1998; 187 (2), 265-270

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.
Elisabeth Stockert, Elke Jäger, Yao-Tseng Chen, Matthew J Scanlan, Ivan Gout, Julia Karbach, Michael Arand, Alexander Knuth, Lloyd J Old. The Journal of Experimental Medicine, 1998; 187 (8), 1349-1354

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.
Elke Jäger, Sacha Gnjatic, Yasuhiro Nagata, Elisabeth Stockert, Dirk Jäger, Julia Karbach, Antje Neumann, Julia Rieckenberg, Yao-Tseng Chen, Gerd Ritter, Eric Hoffman, Michael Arand, Lloyd J Old, Alexander Knuth. Proceedings of the National Academy of Sciences, 2000; 97 (22), 12198-12203

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.
Elke Jäger, Yasuhiro Nagata, Sacha Gnjatic, Hisashi Wada, Elisabeth Stockert, Julia Karbach, P Rod Dunbar, Sang Yull Lee, Achim Jungbluth, Dirk Jäger, Michael Arand, Gerd Ritter, Vincenzo Cerundolo, Bo Dupont, Yao-Tseng Chen, Lloyd J Old, Alexander Knuth. Proceedings of the National Academy of Sciences, 2000; 97 (9), 4760-4765

Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.
Elke Jäger, Julia Karbach, Sacha Gnjatic, Antje Neumann, Armin Bender, Danila Valmori, Maha Ayyoub, Erika Ritter, Gerd Ritter, Dirk Jäger, Dennis Panicali, Eric Hoffman, Linda Pan, Herbert Oettgen, Lloyd J Old, Alexander Knuth. Proceedings of the National Academy of Sciences, 2006; 103 (39), 14453-14458

Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.
Salah-Eddin Al-Batran, Joerg Thomas Hartmann, Stephan Probst, Harald Schmalenberg, Stephan Hollerbach, Ralf Hofheinz, Volker Rethwisch, Gernot Seipelt, Nils Homann, Gerhard Wilhelm, Gunter Schuch, Jan Stoehlmacher, Hans Günter Derigs, Susanna Hegewisch-Becker, Johannes Grossmann, Claudia Pauligk, Akin Atmaca, Carsten Bokemeyer, Alexander Knuth, Elke Jäger. Journal of Clinical Oncology, 2008; 26 (9), 1435-1442